|
|||||
|
|
Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience,severe renal impairment,or genotype 3 infection |
|
| Authors: | Kumada Hiromitsu Watanabe Tsunamasa Suzuki Fumitaka Ikeda Kenji Sato Ken Toyoda Hidenori Atsukawa Masanori Ido Akio Takaki Akinobu Enomoto Nobuyuki Kato Koji Alves Katia Burroughs Margaret Redman Rebecca Pugatch David Pilot-Matias Tami J. Krishnan Preethi Oberoi Rajneet K. Xie Wangang Chayama Kazuaki |
| Affiliation: | 1.Department of Hepatology, Toranomon Hospital, Tokyo, Japan ;2.Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan ;3.Department of Medicine and Molecular Science, Gunma University Hospital, Maebashi, Japan ;4.Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan ;5.Department of Internal Medicine, Nippon Medical School, Tokyo, Japan ;6.Department of Human and Environmental Sciences, Kagoshima University Hospital, Kagoshima, Japan ;7.Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan ;8.The First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan ;9.AbbVie Inc., North Chicago, IL, USA ;10.Department of Gastroenterology and Metabolism, Institute of Biomedical and Health Sciences, Hiroshima University Hospital, Hiroshima, Japan ; |
| Abstract: | Journal of Gastroenterology - Unfortunately, in the original publication of this article, the copyright line was incorrectly published in PDF as “© The Author(s) 2017” instead of... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |